These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 241665)

  • 21. [Comparative study of the reproduction of Sidnbis virus sensitive and resistant to adamantane derivatives].
    Andronova VL; Galegov GA
    Biull Eksp Biol Med; 2000 Jan; 129(1):86-9. PubMed ID: 10710638
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of the new potential anti-Parkinson agent, hymantane, on levels of monoamines and their metabolites in rat striatum (a microdialysis study)].
    Andiarzhanova EA; Val'dman EA; Kudrin VS; Raevskiĭ KS; Voronina TA
    Eksp Klin Farmakol; 2001; 64(6):13-6. PubMed ID: 11871228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines.
    National Toxicology Program
    NTP CERHR MON; 2005 Jul; (16):vii-III1. PubMed ID: 16130031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of the prolonged immunotropic effect of the potential antiparkinson agent himantane].
    Nezhinskaia GI; Val'dman EA; Nazarov PG; Sapronov NS
    Eksp Klin Farmakol; 2003; 66(3):44-6. PubMed ID: 12924233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Progress in the field of drug development. 4].
    Hörig C; Koch H; Mayr E; Selchau M
    Pharmazie; 1972 Jun; 27(6):347-90. PubMed ID: 4404246
    [No Abstract]   [Full Text] [Related]  

  • 26. Design and synthesis of bioactive adamantane spiro heterocycles.
    Kolocouris N; Zoidis G; Foscolos GB; Fytas G; Prathalingham SR; Kelly JM; Naesens L; De Clercq E
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4358-62. PubMed ID: 17588747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of the potential antiparkinsonian agent adamantane derivative on ion channels of NMDA glutamate receptors].
    Elshanskaia MV; Sobolevskiĭ AI; Val'dman EA; Khodorov BI
    Eksp Klin Farmakol; 2001; 64(1):18-21. PubMed ID: 11544796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preparation of various isonicotinoyl-hydrazones of cyclones and isonicotincyl-cycloalkyl-hydrazines].
    Sparatore F; Paglietti G
    Boll Chim Farm; 1967 Jan; 106(1):12-22. PubMed ID: 5608601
    [No Abstract]   [Full Text] [Related]  

  • 29. Design and synthesis of 1,2-annulated adamantane piperidines with anti-influenza virus activity.
    Zoidis G; Kolocouris N; Naesens L; De Clercq E
    Bioorg Med Chem; 2009 Feb; 17(4):1534-41. PubMed ID: 19195900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.
    Wanka L; Iqbal K; Schreiner PR
    Chem Rev; 2013 May; 113(5):3516-604. PubMed ID: 23432396
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis of certain 2-aminoadamantane derivatives as potential antimicrobial agents.
    Eisa HM; Tantawy AS; el-Kerdawy MM
    Pharmazie; 1991 Mar; 46(3):182-4. PubMed ID: 1909034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of 1-boraadamantaneamine derivatives with selective astrocyte vs C6 glioma antiproliferative activity. A novel class of anti-hepatitis C agents with potential to bind CD81.
    Wagner CE; Mohler ML; Kang GS; Miller DD; Geisert EE; Chang YA; Fleischer EB; Shea KJ
    J Med Chem; 2003 Jul; 46(14):2823-33. PubMed ID: 12825926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and bioactivity studies of 1-adamantanamine derivatives of peptides.
    Horvat S; Varga-Defterdarović L; Horvat J; Jukić R; Kantoci D; Chung NN; Schiller PW; Biesert L; Pfützner A; Suhartono H
    J Pept Sci; 1995; 1(5):303-10. PubMed ID: 9223009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of a new antiparkinsonian drug himantane on monoamine oxidase activity].
    Val'dman EA; Voronina TA; Aksenova LN; Buneeva OA; Medvedev AE
    Eksp Klin Farmakol; 2003; 66(5):3-5. PubMed ID: 14650204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hydrazines containing 1H-indene units].
    Ferranti A; Garuti L; Giovanninetti G; Brigidi P
    Farmaco Sci; 1983 Mar; 28(3):167-72. PubMed ID: 6852230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Phosphoric esters of adamantanols, adamantanethiols, adamantyl alcohols and their alkyl derivatives, III: Surface activity and bacteriological tests (author's transl)].
    Böhringer H; Vogt H
    Arch Pharm (Weinheim); 1978 Sep; 311(9):721-7. PubMed ID: 708200
    [No Abstract]   [Full Text] [Related]  

  • 37. [Driving under the influence of amphetamine and metamphetamine].
    Lia K; Spigset O; Slørdal L
    Tidsskr Nor Laegeforen; 2009 Jan; 129(2):105-8. PubMed ID: 19151802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Synthesis and testing of potential antiparkinson agents. 2. Biologically active silicium derivatives].
    Friedrich G; Bartsch R; Rühlmann K
    Pharmazie; 1977 Jul; 32(7):394-7. PubMed ID: 909903
    [No Abstract]   [Full Text] [Related]  

  • 39. N-oxygenation of amphetamine and methamphetamine by the human flavin-containing monooxygenase (form 3): role in bioactivation and detoxication.
    Cashman JR; Xiong YN; Xu L; Janowsky A
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1251-60. PubMed ID: 10027866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and psychopharmacological research. The significance of pharmacokinetic basic data for research of psychopharmaca on human behaviour.
    van Rossum JM
    Psychiatr Neurol Neurochir; 1973; 76(3):217-28. PubMed ID: 4725793
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.